← Open Payments lookup

RAQUEL JOSELYN DIAZ GUERRERO: Open Payments

NPI 1720371032 · SHARON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$822 in 58 payments from 10 companies in 2025. Trend: 2023 $231 · 2024 $195 · 2025 $822

Food & beverage: $822
CompanyPaymentsAmount
ABBVIE INC.23$254
Otsuka America Pharmaceutical, Inc.15$194
Teva Pharmaceuticals USA, Inc.6$106
E.R. Squibb & Sons, L.L.C.4$85
Neurocrine BioSciences, Inc.2$40
Janssen Pharmaceuticals, Inc2$38
Takeda Pharmaceuticals U.S.A., Inc.2$37
Vanda Pharmaceuticals Inc.2$36
Lundbeck LLC1$17
Collegium Pharmaceutical, Inc.1$15

Products named: VRAYLAR, COBENFY, UZEDY, ABILIFY MAINTENA, REXULTI, ABILIFY ASIMTUFII, INGREZZA, TRINTELLIX.

Industry payments across PA — which companies pay providers there.